Inventor
MAJEED MUHAMMED
US127 patents
⚠️ This page may combine multiple inventors who share the name “MAJEED MUHAMMED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAJEED MUHAMMED
26 patentsUS9596861B2Mar 21, 2017
Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
MAJEED MUHAMMED6 citations84
US9579352B2Feb 28, 2017
Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC-37-01, MTCC 5856
MAJEED MUHAMMED7 citations79
US10323227B2Jun 18, 2019
Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
MAJEED MUHAMMED5 citations73
US10792295B2Oct 6, 2020
Compositions for management of Helicobacter pylori infections
MAJEED MUHAMMED5 citations72
US11197898B2Dec 14, 2021
Fructophilic lactic acid producing bacteria
MAJEED MUHAMMED2 citations71
US10172903B2Jan 8, 2019
Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof
MAJEED MUHAMMED2 citations68
US12465585B2Nov 11, 2025
Compositions for the management of seizure induced neurotoxicity
MAJEED MUHAMMED0 citations63
US11458117B2Oct 4, 2022
Compositions and methods for beta secretase inhibition
MAJEED MUHAMMED0 citations63
US10959980B2Mar 30, 2021
Bioactive molecules from oroxylum indicum and their therapeutic applications
MAJEED MUHAMMED0 citations63
US10894029B2Jan 19, 2021
Neuroprotective compositions and their use
MAJEED MUHAMMED0 citations63
US8933121B2Jan 13, 2015
Anti-obesity potential of Calebin A
MAJEED MUHAMMED2 citations63
US12233032B2Feb 25, 2025
Compositions for management of polycystic ovary syndrome
MAJEED MUHAMMED0 citations62
US11957728B2Apr 16, 2024
Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition
MAJEED MUHAMMED0 citations62
US11925606B2Mar 12, 2024
Compositions for managing chronic obstructive pulmonary disease
MAJEED MUHAMMED0 citations62
US11744807B2Sep 5, 2023
Therapeutic compositions and methods for pulmonary fibrosis
MAJEED MUHAMMED0 citations62
US11707438B2Jul 25, 2023
Curcuminoid composition for therapeutic management of metabolic syndrome
MAJEED MUHAMMED0 citations62
US11491119B2Nov 8, 2022
Curcuminoid composition and its therapeutic potential in managing lung fibrosis
MAJEED MUHAMMED0 citations62
US11413318B2Aug 16, 2022
Compositions and methods for management of atrophic gastritis and colitis
MAJEED MUHAMMED0 citations62
US11351102B2Jun 7, 2022
Plant actives and their anti-pollution effects thereof
MAJEED MUHAMMED0 citations62
US11213553B2Jan 4, 2022
Hypolipidemic effects of Bacillus coagulans
MAJEED MUHAMMED0 citations62
US11202810B2Dec 21, 2021
Stable probiotic composition for the management of lactose intolerance
MAJEED MUHAMMED0 citations62
US11122814B2Sep 21, 2021
Beverage compositions containing Bacillus coagulans MTCC 5856
MAJEED MUHAMMED0 citations62
US11052125B2Jul 6, 2021
Compositions for weight loss
MAJEED MUHAMMED1 citations62
US10966919B2Apr 6, 2021
Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856
MAJEED MUHAMMED1 citations62
US10881623B2Jan 5, 2021
Compositions for the management of hyperglycemia and related conditions
MAJEED MUHAMMED0 citations62
US10864154B2Dec 15, 2020
Skin care compositions and their applications
MAJEED MUHAMMED1 citations62
SABINSA CORP
11 patentsUS5536506AJul 16, 1996
Use of piperine to increase the bioavailability of nutritional compounds
SABINSA CORP131 citations97
US5972382AOct 26, 1999
Use of piperine as a bioavailability enhancer
SABINSA CORP44 citations95
US5804596ASep 8, 1998
Method of preparing a forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders
SABINSA CORP59 citations95
US5783603AJul 21, 1998
Potassium hydroxycitrate for the suppression of appetite and induction of weight loss
SABINSA CORP69 citations95
US5744161AApr 28, 1998
Use of piperine as a bioavailability enhancer
SABINSA CORP74 citations94
US6689400B2Feb 10, 2004
Process of obtaining compositions of stable lutein and lutein derivatives
SABINSA CORP20 citations93
US6653327B2Nov 25, 2003
Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays
SABINSA CORP19 citations92
US6998502B1Feb 14, 2006
Convenient process of manufacture for difluoromethylornithine and related compounds
SABINSA CORP28 citations89
US6849645B2Feb 1, 2005
Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
SABINSA CORP30 citations89
US7063861B2Jun 20, 2006
Bioavailable composition of natural and synthetic HCA
SABINSA CORP11 citations84
US6054585AApr 25, 2000
Process for making high purity piperine for nutritional use
SABINSA CORP16 citations84
SAMI LABS LTD
9 patentsUS6794537B1Sep 21, 2004
Manufacturing processes for Se-methyl-L-selenocysteine
SAMI LABS LTD19 citations90
US7253324B1Aug 7, 2007
Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers
SAMI LABS LTD19 citations89
US7202270B2Apr 10, 2007
Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
SAMI LABS LTD14 citations84
US6960300B2Nov 1, 2005
Process for preparing water soluble diterpenes and their applications
SAMI LABS LTD10 citations73
US7014874B1Mar 21, 2006
Compositions and methods containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation
SAMI LABS LTD8 citations71
US7378442B1May 27, 2008
Chemical entities with multiple modes of anti-inflammatory action
SAMI LABS LTD8 citations69
US6982273B1Jan 3, 2006
Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use
SAMI LABS LTD8 citations65
US10609935B2Apr 7, 2020
Beverage compositions containing Bacillus coagulans MTCC 5856
SAMI LABS LTD1 citations62
US7582314B2Sep 1, 2009
Compositions and methods for the management of hyperproliferative dermatological conditions
SAMI LABS LTD5 citations62
SIGNPATH PHARMA INC
3 patentsUS10258691B2Apr 16, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations84
US10238602B2Mar 26, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations84
US10449193B2Oct 22, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC13 citations82
SAMI CHEMICALS & EXTRACTS LTD
1 patentShowing the top 50 of 127 patents by PatentIndex Score.